We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$505M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$83.5M |
| 2 |
S&P Global
SPGI
|
+$73.5M |
| 3 |
Tesla
TSLA
|
+$55.8M |
| 4 |
Microsoft
MSFT
|
+$45.9M |
| 5 |
Amazon
AMZN
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$31.7M |
| 4 |
Abbott
ABT
|
+$25.5M |
| 5 |
Exelon
EXC
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLP
2201
One Liberty Properties
OLP
$512M
| $847K | ﹤0.01% |
27,496
-1,668
| -6% | -$51.7K |
|
2202
Smith & Wesson
SWBI
$636M
| $845K | ﹤0.01% |
55,837
-686
| -1% | -$11.5K |
|
|
VERV
2203
DELISTED
Verve Therapeutics
VERV
| $844K | ﹤0.01% |
36,980
+19,156
| +107% | +$547K |
|
|
CVAC
2204
DELISTED
CureVac
CVAC
| $838K | ﹤0.01% |
42,715
-5,054
| -11% | -$101K |
|
2205
Anavex Life Sciences
AVXL
$314M
| $837K | ﹤0.01% |
68,017
+6,906
| +11% | +$84.9K |
|
2206
ARKO Corp
ARKO
$527M
| $835K | ﹤0.01% |
91,709
-17,336
| -16% | -$146K |
|
2207
eHealth
EHTH
$40.4M
| $835K | ﹤0.01% |
67,278
+869
| +1% | +$15K |
|
2208
Petco
WOOF
$765M
| $832K | ﹤0.01% |
42,537
-13,014
| -23% | -$243K |
|
|
CONN
2209
DELISTED
Conn's Inc.
CONN
| $829K | ﹤0.01% |
53,773
-1,880
| -3% | -$40.5K |
|
2210
BioLife Solutions
BLFS
$1.69B
| $823K | ﹤0.01% |
36,198
-15,874
| -30% | -$418K |
|
|
KDNY
2211
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $821K | ﹤0.01% |
50,184
+4,362
| +10% | +$59.3K |
|
2212
Anterix
ATEX
$1.81B
| $817K | ﹤0.01% |
14,105
-1,301
| -8% | -$71.2K |
|
|
FBMS
2213
DELISTED
The First Bancshares, Inc.
FBMS
| $815K | ﹤0.01% |
24,216
-2,507
| -9% | -$91K |
|
|
FIRY
2214
Firy Inc
FIRY
$164M
| $814K | ﹤0.01% |
13,568
-696
| -5% | -$56.8K |
|
|
HTBK
2215
DELISTED
Heritage Commerce
HTBK
| $812K | ﹤0.01% |
72,167
-6,974
| -9% | -$83.6K |
|
2216
Yext
YEXT
$577M
| $812K | ﹤0.01% |
117,825
+1,584
| +1% | +$12.1K |
|
|
CFB
2217
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $810K | ﹤0.01% |
51,366
-3,455
| -6% | -$54.7K |
|
2218
Clearfield
CLFD
$391M
| $808K | ﹤0.01% |
12,386
-26
| -0.2% | -$1.63K |
|
2219
Stoneridge
SRI
$203M
| $808K | ﹤0.01% |
38,914
-3,955
| -9% | -$72.8K |
|
2220
Fulcrum Therapeutics
FULC
$286M
| $807K | ﹤0.01% |
34,115
+2,408
| +8% | +$34.1K |
|
2221
Byline Bancorp
BY
$1.75B
| $806K | ﹤0.01% |
30,227
-3,040
| -9% | -$82.8K |
|
2222
Microvision
MVIS
$86.9M
| $805K | ﹤0.01% |
11,493
+286
| +3% | +$16.9K |
|
|
SGFY
2223
DELISTED
Signify Health, Inc.
SGFY
| $801K | ﹤0.01% |
44,135
-12,349
| -22% | -$177K |
|
2224
Ecovyst
ECVT
$1.1B
| $797K | ﹤0.01% |
68,952
-928
| -1% | -$9.73K |
|
2225
Globalstar
GSAT
$10.9B
| $796K | ﹤0.01% |
36,100
-812
| -2% | -$13.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
- RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
- RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
- RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
- RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
- RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.